rosiglitazone
美 
英
例句
Rosiglitazone was taken off the market in Europe, and its use is greatly restricted in the United States.
羅格列酮已經撤出歐洲市場，在美國的使用也被大大限制。
Earlier studies on treating diabetes had suggested rosiglitazone and a second drug, ramipril, might also halt progression to diabetes.
早期關于糖尿病治療的研究表明，羅格列酮和另外一種藥物雷米普利可能阻止發展為糖尿病。
Rosiglitazone and pioglitazone are part of a group of drugs called thiazolidinediones.
羅格列酮和吡咯列酮同屬噻唑烷二酮類。
When rosiglitazone was first authorised in the EU in 2000, it was contraindicated in patients with a history of cardiac failure.
2000年歐盟首次批準使用羅格列酮時，就其應用于心衰病史患者身上就存在著爭議。
Daily cost of glibenclamide and metformin was low, and gliquidone was medium and rosiglitazone was expensive.
格列本脲、二甲雙胍每日藥費較低，格列喹酮價格適中，羅格列酮屬價格較高品種。
Like insulin and other diabetes drugs, rosiglitazone and a similar drug, pioglitazone (Actos), lower blood sugar.
像胰島素和其他降糖藥物一樣，文迪亞與一種與其相似的藥物比格列酮一樣，具有降血糖的作用。
The aim of this meta-analysis of randomized clinical trials is to assess the effect of rosiglitazone on the incidence of cancer.
這項對隨機臨床試驗薈萃分析的目的是評價羅格列酮對腫瘤發生率的影響。
International Diabetes: Do rosiglitazone and pioglitazone have different or similar properties in respect to their cardiovascular profiles?
《國際糖尿病》：羅格列酮和吡格列酮對心血管的影響是否有所差別？二者有何相似性？
Has some of the bad press and issues with rosiglitazone unfairly affected pioglitazone?
有關羅格列酮的一些負面新聞是否會對吡格列酮有影響？
International Diabetes: Does pioglitazone have more favorable effects on serum lipids than rosiglitazone?
《國際糖尿病》：吡格列酮對血脂的作用是否優于羅格列酮？
AIM: To observe the roles of rosiglitazone (RSG) in unilateral ureteral obstruction (UUO) rats renal interstitial fibrosis.
目的：探討羅格列酮（RSG）對單側輸尿管梗阻（UUO）大鼠腎間質纖維化的保護作用及其機制。
The vascular lesions in diabetes mellitus rosiglitazone treatment group were less severe than those in diabetes mellitus group.
糖尿病羅格列酮治療組大鼠血管病變明顯輕于糖尿病組；
The rosiglitazone story thus carries lessons for scientists, practitioners, and regulators alike.
羅格列酮事件給科學家們、醫生們和政策調節者們都上了一課。
most of the fractures seen in the women taking rosiglitazone affected bones in the upper arm , hand , or foot.
所觀察到的羅格列酮組女性患者發生骨折的最常見部位是上臂、手和足。
CONCLUSION Rosiglitazone maleate possesses the insulin sensitizing effect and could be used in the treatment of type 2 diabetes.
結論羅格列酮具有胰島素增敏作用，對2型糖尿病有治療作用。
During that time, women taking rosiglitazone were more likely to have bone fractures than women taking either metformin or glyburide.
隨訪期間，羅格列酮組的女性患者骨折發生率明顯高于二甲雙胍組和格列本脲組。
Adjusting for potential confounding factors, individuals on rosiglitazone had 15% higher rate of death and 13% higher risk of heart failure.
調整潛在的混雜因素后，服用羅格列酮的病人比服用匹格列酮的病人的死亡率高15%，心衰風險高13%。
Objective To evaluate the effect of insulin sensitized agent (rosiglitazone), on blood pressure in spontaneous hypertensive rats (SHR).
目的為了初步了解胰島素增敏劑羅格列酮對自發性高血壓大鼠的降壓作用和機理，設計了本項實驗。
This may apply to drugs other than rosiglitazone also, but our experience was specifically with rosiglitazone.
這可能也適用于羅格列酮以外的藥物，但我們的經驗是羅格列酮專有的。
The US Food and Drug Administration (FDA) recently released a rosiglitazone risk management strategy.
美國食品和藥物管理局（FDA）最近發布了羅格列酮的風險管理策略。
No difference between rosiglitazone and pioglitazone was apparent.
羅格列酮和匹格列酮間無明顯差別。
OBJECTIVE: To observe the effects of PA on IL-6 secretion and the influences of rosiglitazone(RSG) on them in cultured human adipocytes.
目的：觀察軟脂酸（PA）對糖尿病及非糖尿病人成熟脂肪細胞分泌IL-6的影響及羅格列酮（RSG）干預的效果。
Beginning in 1999, rosiglitazone maleate and pioglitazone hydrochloride were approved for use.
從1999年開始，馬來酸羅格列酮和鹽酸匹格列酮被批準使用。
Rosiglitazone increases the sensitivity of cells to insulin.
羅格列酮可以增加細胞對胰島素的敏感性。
Objective To evaluate the clinical efficacy and safety of rosiglitazone for treatment of type 2 diabetics with fatty liver.
目的臨床觀察胰島素增敏劑羅格列酮對2型糖尿病合并脂肪肝患都臺療的有效性和安全性。
Patients taking pioglitazone averaged 380 days of medication, and patients taking rosiglitazone averaged 369 days of medication.
服用匹格列酮的病人平均進行了380天的治療，服用羅格列酮的病人平均進行了369天的治療。
What is the mechanism of the synergy between rosiglitazone and carboplatin?
羅格列酮與卡鉑協同作用的機制是什么呢？
Aim To investigate the effect of rosiglitazone on glucose-induced adhesion of human endothelial cells.
目的研究羅格列酮對高糖誘導的內皮細胞黏附作用的影響。
In the present investigation we evaluated the effects of PPAR agonist rosiglitazone onto the hippocampus of status epilepticus rats.
本實驗的目的是評價羅格列酮在大鼠癲癇持續狀態中的作用。
Bones often affected by osteoporosis (such as the hip or spine) weren't more likely to fracture in the women on rosiglitazone.
然而，骨質疏松導致的骨折（如髖部和脊柱）在羅格列酮組的女性患者中并不增加。
Rosiglitazone was put into the drinking water. The observing time was 8 weeks.
羅格列酮為觀察藥，溶于飲水中，實驗期8周。
The GJB resulted in better glucose control in comparison to weight loss from food restriction and to rosiglitazone therapy [12].
與節食減肥和羅格列酮治療相比，GJB在血糖控制方面的結果更好[12]。
Although, the rosiglitazone story remains clouded and so we are currently waiting from data from ongoing studies to have a clearer picture.
雖然，羅格列酮的故事還不明朗，因此目前我們仍在等待正在進行中的研究的數據，從而有一個更清楚的了解。
As such, the researchers say it is difficult to advocate continued use of rosiglitazone for most patients.
研究者說，照這樣看，將很難提倡大部分的患者繼續使用羅格列酮。
In these trials, 15 560 patients were assigned to rosiglitazone and 12 283 received placebo or an active comparator.
在這些試驗中，15560名受試者被分配到羅格列酮組，12283接受安慰劑或活性對比藥物組。
Morphology research on the protecting effect of rosiglitazone on the heart of spontaneously hypertensive rats
羅格列酮對自發性高血壓大鼠心臟保護作用的形態學研究
Contrast study of the effect of Irbesartan and Irbesartan combined Rosiglitazone on lipoprotein lipase of insulin resistance SD rats
伊貝沙坦與合用羅格列酮對胰島素抵抗SD大鼠脂蛋白酯酶影響的對比研究
The Clinical Intervention Study Of Rosiglitazone In The Patients With Impaired Glucose Homeostasis
文迪雅對糖穩態受損的臨床干預研究
Experimental Study of Rosiglitazone in Preventing Renal Interstitial Fibrosis in Rats
羅格列酮抑制大鼠腎間質纖維化的實驗研究
Protection of rosiglitazone against renal interstitial lesion and its mechanism
羅格列酮對腎間質損傷的防護作用及其機制
